H2020Индивидуална стипендия2017–2019

meltRBP · Tracking interactions between RNA and RNA-binding proteins by thermal profiling of the proteome

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2017-04-01 → 2019-03-31
Финансиране от ЕС
171 461 €
Участници
1
Схема
MSCA-IF-EF-ST

Линиите свързват координатора с партньорите.

Накратко на български

Взаимодействията между РНК и протеините, които се свързват с нея, се проучват чрез нов метод за термично профилиране. Това помага да се разбере как тези протеини регулират процеси като превода и разграждането на генетичната информация в клетката.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Tracking interactions between RNA and RNA-binding proteins by thermal profiling of the proteome

RNA-binding proteins (RBPs) are among the key regulators of post-transcriptional processes and help cells to adapt to changing internal and external stimuli. The exploration of how RBPs perform their complex tasks of organising alternative splicing, polyadenylation, mRNA localisation, translation and degradation is crucial, as they are fundamental gene- regulatory processes. To unravel the function of a specific RBP, it is necessary to determine its binding sites and its regulatory effects on target transcripts. So far, many techniques have been protein-centric and required the immunoprecipitation of an individual protein with its interacting RNAs (CLIP-based techniques). However, approaches based on the principle that individual RNAs are only bound by one RBP at any point in time are too simplistic. Most RNAs are bound by a variety of different RBPs at the same time or sequentially throughout their life cycle. Therefore, it is essential to identify the pool of all RBPs that directly bind to a specific RNA in order to understand the RNA’s regulation. So far, techniques used RNA as bait in order to identify interacting proteins. The RNA is immobilised on a solid support and after thorough washing, the RNP complexes (RBPs bound to RNA) can be identified through mass spectrometry. Alternatively, the RNA can be tagged with e.g. modified ribonucleosides. Even though these techniques are able to identify in vivo and in vitro RNA-RBP interactions, they suffer from several disadvantages, such as perturbations of RNA folding through the insertion of a tag, the need for large amounts of input material, limited identification of non-abundant targets, and limited throughput. To overcome such limitations, I proposed to develop a new method, which aims at uncovering all of the RBPs bound to a specific RNA without the need for RNA or protein enrichment. This novel technique should allow the unbiased identification of RBPs directly bound to a specific RNA target within cells. In 2014, Dr Mikhail Savitski, group leader at EMBL, developed a novel approach, termed thermal proteome profiling (TPP). This methodology is based on the principle that the binding of a ligand to a protein causes a shift in its stability, which can be read out by the proteins’ denaturing properties, using the cellular thermal shift assay (CETSA). In detail, target engagement is measured by exposing the intact cells to a range of different temperatures (37¬¬–65°C, at increments of 3°C). Thereby, a specific temperature induces unfolding of a protein, which leads to the formation of an insoluble pellet after centrifugation. The supernatant now contains all the proteins that are stable at the given temperature, which can be quantified either by Western blotting for specific targets, or on a proteome-wide scale using mass spectrometry. The addition of a drug, as in Savitski et al., (2014), perturbs the system and results in specific protein melting point differences. The project proposed here made use of this innovative approach, by transferring this cutting-edge technology to the study of RNA-protein complexes and identify all of the RBPs that are bound to a specific RNA. One major advantage of this application is that the differential effects on protein stability modulated by the concentration of a specific RNA molecule can be measured in the context of the whole cell. Specifically, we optimised the technique with a well-characterized model system, the iron regulatory protein/iron response element interaction, followed by the application of TPP to discover all RBPs bound to the iron response element of the HIF2 5’untranslated region. Trying to apply TPP to a novel context, directed our interest to Enolase 1, a glycolytic enzyme that binds RNA.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

RNA-binding proteins (RBPs) are among the key players in post-transcriptional gene regulation. A detailed knowledge of the RBPs bound to a specific RNA target is critical to the unravelling of the regulatory steps of RNA expression under normal and disease conditions. However, the study of these interactions is complex and requires methodologies that go beyond the scope of individual RBPs. So far, the techniques have been confined to post-lysis protein or RNA enrichment, which limits the identification of non-abundant targets and often relies on the insertion of tags.To solve these issues, thermal proteome profiling (TPP)—relying on the stabilisation of the endogenous protein through the binding of its ligand—will be applied in this project. Here, using mass spectrometry, TPP will be applied to investigate complex RBP-RNA interactions on a proteome-wide level in an unbiased manner ('meltRBP'). First, the methodology will be benchmarked with the help of a well-characterised interaction: the iron regulatory proteins and their RNA target, the iron response element (IRE). Secondly, TPP will be applied to a biologically relevant system, namely the mRNA of the Amyloid Beta Precursor Protein (APP). The proteolysis of mutant APP proteins, which are generated from alternatively spliced mRNAs, generates highly aggregation-prone β-amyloid peptides, a hallmark of Alzheimer’s disease (AD). The application of TPP to identify RBPs bound to the wild-type versus mutant APP mRNA will reveal new potential targets for AD treatment. Finally, TPP will be used to determine the specificity of the hybridisation of antisense oligonucleotides (ASOs), currently of great interest to the field of neurodegenerative disease treatment and whose global cellular effects have thus far not been investigated in a high-throughput manner.In summary, this proposal encompasses the benchmarking and application of an innovative proteomic technique, that has the potential to function as a screen for ASOs.

Оригинален текст от CORDIS (на английски).

Участници

  • EUROPEAN MOLECULAR BIOLOGY LABORATORY · HeidelbergКоординаторГермания

Връзки

Данни: CORDIS, © Европейски съюз